Capital Planning Advisors Has Lowered Its Facebook (FB) Position by $1.01 Million as Stock Price Declined; Cvs Health (Put) (CVS) Shareholder Equitec Proprietary Markets Boosted Its Stake

Facebook, Inc. (NASDAQ:FB) Logo

Capital Planning Advisors Llc decreased its stake in Facebook Inc (FB) by 12.87% based on its latest 2018Q3 regulatory filing with the SEC. Capital Planning Advisors Llc sold 6,163 shares as the company’s stock declined 13.60% with the market. The hedge fund held 41,715 shares of the technology company at the end of 2018Q3, valued at $6.86 million, down from 47,878 at the end of the previous reported quarter. Capital Planning Advisors Llc who had been investing in Facebook Inc for a number of months, seems to be less bullish one the $417.33 billion market cap company. The stock increased 0.99% or $1.42 during the last trading session, reaching $145.22. About 12.91M shares traded. Facebook, Inc. (NASDAQ:FB) has declined 21.26% since January 14, 2018 and is downtrending. It has underperformed by 21.26% the S&P500. Some Historical FB News: 26/03/2018 – Tech Among Market’s Biggest Gainers, But Facebook Continues To Drag — MarketWatch; 09/04/2018 – Voice of Amer: Americans’ Trust of Facebook Nosedives; 19/03/2018 – Facebook Is Pummeled by User-Data Blowback; 09/04/2018 – Facebook’s Zuckerberg to Meet Lawmakers Ahead of Tough Questions; 04/05/2018 – New York Post: Facebook weighs ad-free subscription service after data scandal; 08/04/2018 – Facebook has spent the last couple of weeks trying to transform its public image; 21/04/2018 – Facebook used to hate pre-roll video ads. Now it’s changing its mind:; 17/04/2018 – Insurance Executive Fred R. Donner Joins FTI Consulting; 20/03/2018 – U.S. Government Has ‘Unbelievable Case Against Facebook,’ Says Zell (Video); 19/04/2018 – FB: DISABLING THE ABILITY TO RESOLVE THE APP-SCOPED USER ID

Equitec Proprietary Markets Llc increased its stake in Cvs Health Corp (Put) (CVS) by 257.14% based on its latest 2018Q3 regulatory filing with the SEC. Equitec Proprietary Markets Llc bought 10,800 shares as the company’s stock declined 3.04% with the market. The institutional investor held 15,000 shares of the medical and nursing services company at the end of 2018Q3, valued at $1.18 million, up from 4,200 at the end of the previous reported quarter. Equitec Proprietary Markets Llc who had been investing in Cvs Health Corp (Put) for a number of months, seems to be bullish on the $84.38 billion market cap company. The stock decreased 0.85% or $0.56 during the last trading session, reaching $65.25. About 6.18M shares traded. CVS Health Corporation (NYSE:CVS) has risen 3.17% since January 14, 2018 and is uptrending. It has outperformed by 3.17% the S&P500.

Among 57 analysts covering Facebook (NASDAQ:FB), 48 have Buy rating, 2 Sell and 7 Hold. Therefore 84% are positive. Facebook had 310 analyst reports since July 21, 2015 according to SRatingsIntel. On Thursday, August 27 the stock rating was maintained by Cantor Fitzgerald with “Buy”. Citigroup maintained Facebook, Inc. (NASDAQ:FB) on Tuesday, October 16 with “Buy” rating. The rating was maintained by Needham on Wednesday, July 19 with “Buy”. On Thursday, November 5 the stock rating was maintained by Deutsche Bank with “Buy”. Monness maintained Facebook, Inc. (NASDAQ:FB) rating on Thursday, April 26. Monness has “Buy” rating and $22500 target. The firm earned “Buy” rating on Tuesday, September 8 by Moffett Nathanson. On Wednesday, October 11 the stock rating was maintained by RBC Capital Markets with “Buy”. The stock has “Buy” rating by Cowen & Co on Friday, July 14. The firm earned “Outperform” rating on Thursday, July 30 by Oppenheimer. On Thursday, November 2 the stock rating was maintained by Canaccord Genuity with “Buy”.

Since July 16, 2018, it had 0 buys, and 61 sales for $985.98 million activity. $509,438 worth of Facebook, Inc. (NASDAQ:FB) was sold by FISCHER DAVID B. on Monday, October 1. Stretch Colin sold $161,858 worth of stock or 750 shares. Schroepfer Michael Todd had sold 38,037 shares worth $6.87 million. On Thursday, July 19 Zuckerberg Mark sold $100.45 million worth of Facebook, Inc. (NASDAQ:FB) or 480,000 shares. 9,522 shares valued at $1.72M were sold by Wehner David M. on Wednesday, August 15. Sandberg Sheryl sold 55,000 shares worth $7.79 million.

Capital Planning Advisors Llc, which manages about $180.00 million and $312.94 million US Long portfolio, upped its stake in Honeywell Intl Inc (NYSE:HON) by 3,789 shares to 22,079 shares, valued at $3.67M in 2018Q3, according to the filing. It also increased its holding in Ishares Tr (IJR) by 40,729 shares in the quarter, for a total of 188,241 shares, and has risen its stake in Ishares Tr (IYW).

More notable recent Facebook, Inc. (NASDAQ:FB) news were published by: Seekingalpha.com which released: “Facebook’s Network Shows No Signs Of Cracking – Seeking Alpha” on December 21, 2018, also Livetradingnews.com with their article: “Facebook, Inc. (NASDAQ:FB) valuation says the stock is an absolute steal – Live Trading News” published on December 18, 2018, Seekingalpha.com published: “Facebook facing ban on some data-gathering in Germany – Seeking Alpha” on January 14, 2019. More interesting news about Facebook, Inc. (NASDAQ:FB) were released by: Nasdaq.com and their article: “Facebook Earnings: Mark Your Calendar – Nasdaq” published on January 04, 2019 as well as Seekingalpha.com‘s news article titled: “Facebook Looks Like ‘Dead Money’ – Seeking Alpha” with publication date: December 17, 2018.

Analysts await Facebook, Inc. (NASDAQ:FB) to report earnings on January, 30 after the close. They expect $2.17 earnings per share, down 1.36% or $0.03 from last year’s $2.2 per share. FB’s profit will be $6.24B for 16.73 P/E if the $2.17 EPS becomes a reality. After $1.76 actual earnings per share reported by Facebook, Inc. for the previous quarter, Wall Street now forecasts 23.30% EPS growth.

Investors sentiment increased to 1.13 in 2018 Q3. Its up 0.04, from 1.09 in 2018Q2. It is positive, as 123 investors sold FB shares while 598 reduced holdings. 154 funds opened positions while 661 raised stakes. 1.61 billion shares or 3.39% less from 1.66 billion shares in 2018Q2 were reported. Paradigm Financial Advisors Ltd invested 0.26% in Facebook, Inc. (NASDAQ:FB). 30,965 were reported by Willis Invest Counsel. Neumann Capital Management Ltd Limited Liability Company owns 1,410 shares. Cim Mangement invested 0.26% of its portfolio in Facebook, Inc. (NASDAQ:FB). Massmutual Tru Fsb Adv accumulated 50,598 shares or 0% of the stock. Boston Family Office Ltd reported 0.26% of its portfolio in Facebook, Inc. (NASDAQ:FB). Tiger Eye Limited Liability Corp invested in 0.17% or 5,635 shares. Aimz Investment Advsr, California-based fund reported 12,916 shares. Driehaus Cap Mngmt reported 2,717 shares or 0.01% of all its holdings. Moreover, Augustine Asset Mgmt Inc has 0.24% invested in Facebook, Inc. (NASDAQ:FB). Clark Estates Inc New York stated it has 60,000 shares or 1.48% of all its holdings. Wallington Asset Management Ltd Co stated it has 2.25% of its portfolio in Facebook, Inc. (NASDAQ:FB). Myriad Asset Mngmt Limited holds 37,700 shares. Mason Street Advsrs Ltd Liability Com owns 339,031 shares. Illinois-based Northern Tru Corporation has invested 1.08% in Facebook, Inc. (NASDAQ:FB).

Among 28 analysts covering CVS Health (NYSE:CVS), 22 have Buy rating, 0 Sell and 6 Hold. Therefore 79% are positive. CVS Health had 85 analyst reports since July 22, 2015 according to SRatingsIntel. Barclays Capital reinitiated CVS Health Corporation (NYSE:CVS) on Thursday, March 10 with “Overweight” rating. The stock of CVS Health Corporation (NYSE:CVS) has “Neutral” rating given on Tuesday, February 13 by Citigroup. The rating was maintained by Jefferies with “Buy” on Thursday, May 12. The firm has “Buy” rating by SunTrust given on Thursday, January 4. The stock of CVS Health Corporation (NYSE:CVS) has “Buy” rating given on Monday, November 26 by Cantor Fitzgerald. The rating was maintained by Jefferies with “Hold” on Friday, June 9. Leerink Swann maintained the stock with “Buy” rating in Tuesday, April 10 report. As per Friday, January 5, the company rating was upgraded by Morgan Stanley. RBC Capital Markets maintained it with “Buy” rating and $89.0 target in Thursday, February 8 report. The firm has “Buy” rating by Citigroup given on Monday, July 9.

Investors sentiment increased to 1.12 in 2018 Q3. Its up 0.05, from 1.07 in 2018Q2. It is positive, as 76 investors sold CVS shares while 459 reduced holdings. 144 funds opened positions while 456 raised stakes. 828.14 million shares or 1.36% more from 816.99 million shares in 2018Q2 were reported. Reilly Advsr Limited Liability, California-based fund reported 100 shares. Cornerstone Advsrs Incorporated reported 0.53% stake. Salem Mngmt holds 14,254 shares. Acadian Asset Management Limited Liability Company reported 9,761 shares. Cypress Cap Grp owns 16,053 shares. Daiwa Secs Grp holds 82,960 shares. 12,978 are owned by Rathbone Brothers Public Ltd Liability Corporation. Fayerweather Charles invested in 23,507 shares. 446,860 were reported by Bartlett & Com Lc. Rhenman & Asset Mgmt Ab has 3.46% invested in CVS Health Corporation (NYSE:CVS) for 438,868 shares. Roffman Miller Assocs Inc Pa has invested 0.03% in CVS Health Corporation (NYSE:CVS). Coatue Management Ltd Limited Liability Company accumulated 2,587 shares. Rothschild And Com Asset Mgmt Us stated it has 0.21% in CVS Health Corporation (NYSE:CVS). Beacon owns 134,434 shares. Aviva Public Limited Company has 631,824 shares.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Seekingalpha.com which released: “Judge accepts CVS changes for Aetna buy – Seeking Alpha” on December 24, 2018, also Seekingalpha.com with their article: “Judge denies shutdown-based request for stay of Aetna-CVS case – Seeking Alpha” published on January 12, 2019, Livetradingnews.com published: “CVS Health Corporation (NYSE:CVS) 2019 down to $50 – Live Trading News” on January 02, 2019. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Investorplace.com and their article: “7 ‘Strong Buy’ Defensive Stocks For 2019 – Investorplace.com” published on December 31, 2018 as well as Seekingalpha.com‘s news article titled: “Bill Nygren Market Commentary Q4 2018 – Seeking Alpha” with publication date: January 13, 2019.

Since August 27, 2018, it had 0 buys, and 7 selling transactions for $18.41 million activity. The insider Denton David M sold 25,159 shares worth $2.02M. On Tuesday, January 8 the insider MERLO LARRY J sold $11.49M. Hourican Kevin also sold $642,300 worth of CVS Health Corporation (NYSE:CVS) on Monday, August 27. $1.72M worth of CVS Health Corporation (NYSE:CVS) shares were sold by Bisaccia Lisa. On Wednesday, November 14 Brennan Troyen A sold $1.17 million worth of CVS Health Corporation (NYSE:CVS) or 14,229 shares.

Equitec Proprietary Markets Llc, which manages about $224.97M US Long portfolio, decreased its stake in Rockwell Collins Inc (Call) (NYSE:COL) by 15,300 shares to 14,500 shares, valued at $2.04M in 2018Q3, according to the filing. It also reduced its holding in Intrexon Corp (Put) (NYSE:XON) by 64,300 shares in the quarter, leaving it with 14,500 shares, and cut its stake in At&T Inc (NYSE:T).

Facebook, Inc. (NASDAQ:FB) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.